# Whole Body HER2 Quantification With 89Zr-Trastuzumab PET/CT to Asses Zr-trastuzumab Accumulation in HER2-mutated and HER2-overexpressing Metastatic Non-small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-08-11

Status: NOT_YET_RECRUITING · Sponsor: The Netherlands Cancer Institute · Condition: Lung Cancer (NSCLC)

- Company: The Netherlands Cancer Institute
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07436858

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.